Stocks of breast cancer drug Olema could more than double from now on, analysts say
Wall Street is optimistic that Olema Pharmaceuticals could be developing the next big breakthrough in breast cancer treatment. Earlier this…
Olema Pharmaceuticals Inc.
This little-known oncology stock could rise more than 70%, says Citi
Olema Oncology could be a leading player in developing therapies for women's cancer, particularly breast cancer, according to Citi Research.…
Analysts Love These Biotech Stocks, Giving 4 an Over 100% Lead
The healthcare sector may have done poorly in recent years, but analysts are optimistic about it at the moment. “Just…